Granulocyte myeloid-derived suppressor cells (g-MDSC’s) are recruited by IL-8, GM-CSF, TNF-alpha, YAP1, CXCR2, and CCL2, conferring tumor immunotherapy resistance to CRC (96–99). The gene discussed is CCL2; the disease is neoplasm.